# Meningeal lymphatic vessel dysfunction exacerbates brain injury in CVST mice via endoplasmic reticulum and oxidative stress pathways

**Authors:** Jianbin Ying, Jun Li, Xianqun Wu, Xuanjie Chen, Hao Zhang, Liangfeng Wei, Junjie Jing, Shousen Wang

PMC · DOI: 10.3389/fimmu.2026.1745066 · Frontiers in Immunology · 2026-01-30

## TL;DR

This study shows that impaired meningeal lymphatic vessels worsen brain injury after cerebral venous sinus thrombosis by increasing inflammation and stress in brain cells.

## Contribution

The study reveals a novel mechanism linking meningeal lymphatic dysfunction to brain injury via endoplasmic reticulum and oxidative stress pathways in CVST.

## Key findings

- Lymphatic dysfunction worsened neurological deficits and brain injury in CVST mice.
- ER stress and inflammation markers were elevated in mice with impaired meningeal lymphatics.
- ER stress inhibition reduced brain injury and inflammation in the CVST+Ligation group.

## Abstract

Meningeal lymphatic vessels (mLVs) play a significant role in neurological homeostasis and disease. However, their contribution to brain injury following cerebral venous sinus thrombosis (CVST) remains unknown. This study investigated whether mLV dysfunction influences the pathological progression of CVST by regulating the endoplasmic reticulum (ER) and oxidative stress(OS)pathways.

A total of 65 male C57BL/6J mice were randomly assigned to four groups: sham-operated, CVST; CVST combined with cervical lymph node ligation (CVST + Ligation); and 4-phenylbutyric acid (4-PBA) intervention. The CVST model was established by inducing thrombosis in the superior sagittal sinus. All sample collection and experimental assays were performed at 2 days post-modeling. Neurobehavioral assessment, histopathological staining, immunofluorescence, western blotting, reverse transcription quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and bioinformatics analyses were employed to comprehensively evaluate neurological function, brain injury, inflammatory response, key molecular expression in ER/oxidative stress pathways, and alterations in related signaling pathways following mLV dysfunction.

Compared to the CVST group, mice in the CVST+Ligation group exhibited more severe neurological deficits, aggravated histopathological brain injury, increased neuronal loss, and enhanced cellular apoptosis. Transcriptomic analysis following lymphatic dysfunction revealed significant enrichment of pathways related to inflammatory response, cytokine-cytokine receptor interaction, and endoplasmic reticulum (ER) stress. At the levels of immunofluorescence, ELISA, Western blot, and mRNA expression, lymphatic ligation significantly upregulated markers of ER stress and microglial activation/apoptosis (including GRP78, CHOP, ATF4, p-eIF2α, NLRP3, and IL-1β) (P < 0.05), as well as downstream apoptosis-related proteins (such as PUMA and Caspase-12) (P < 0.05). It also promoted the release of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α, and IL-17) (P < 0.05). Administration of the ER stress inhibitor 4-PBA effectively reversed these molecular alterations and significantly alleviated brain injury and neuroinflammation in CVST+Ligation mice.

Dysfunction of mLVs exacerbates brain injury after CVST by promoting neuroinflammation via the ER and oxidative stress pathways. Therapeutically targeting mLVs may represent promising strategies for managing CVST-related neurological injury.

## Linked entities

- **Genes:** HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309], DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649], ATF4 (activating transcription factor 4) [NCBI Gene 468], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], IL1B (interleukin 1 beta) [NCBI Gene 3553], BBC3 (BCL2 binding component 3) [NCBI Gene 27113], Caspase-12 (caspase-12) [NCBI Gene 101725565]
- **Proteins:** HSPA5 (heat shock protein family A (Hsp70) member 5), DDIT3 (DNA damage inducible transcript 3), ATF4 (activating transcription factor 4), NLRP3 (NLR family pyrin domain containing 3), IL1B (interleukin 1 beta), BBC3 (BCL2 binding component 3), Caspase-12 (caspase-12)
- **Chemicals:** 4-phenylbutyric acid (PubChem CID 4775), IL-6 (PubChem CID 165368475)
- **Diseases:** brain injury (MONDO:0043510)

## Full-text entities

- **Genes:** Hspa5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 14828] {aka Bip, D2Wsu141e, D2Wsu17e, Grp78, Hsce70, SEZ-7}, Eif2a (eukaryotic translation initiation factor 2A) [NCBI Gene 229317] {aka D030048D22, D3Ertd194e}, Bbc3 (BCL2 binding component 3) [NCBI Gene 170770] {aka PUMA, PUMA/JFY1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Ddit3 (DNA-damage inducible transcript 3) [NCBI Gene 13198] {aka AltDDIT3, CHOP-10, CHOP10, chop, gadd153}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Casp12 (caspase 12) [NCBI Gene 12364], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}
- **Diseases:** Dysfunction (MESH:D006331), neuronal loss (MESH:D009410), brain injury (MESH:D001930), neurological injury (MESH:D020196), thrombosis (MESH:D013927), lymphatic dysfunction (MESH:D008206), neurological deficits (MESH:D009461), inflammatory (MESH:D007249), neuroinflammation (MESH:D000090862), CVST (MESH:D012851)
- **Chemicals:** 4-PBA (MESH:C075773)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12900663/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12900663/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12900663/full.md

---
Source: https://tomesphere.com/paper/PMC12900663